High-intensity Interval Exercise and Chocolate Milk on Blood Glucose and Cognition
NCT03305107, Not applicable, Completed, Toronto Metropolitan University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | High-intensity Interval Exercise and Chocolate Milk on Blood Glucose and Cognition | ClinicalTrials.gov |
| NCT number | NCT03305107 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 20 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Toronto Metropolitan University | ClinicalTrials.gov |
| Conditions | Glycemic Response, Cognitive Function | ClinicalTrials.gov |
| Interventions | Exercise and Chocolate Milk, Exercise and Water, Sitting and Chocolate Milk, Sitting and Water | ClinicalTrials.gov |
| First posted | 2017-10-09 | ClinicalTrials.gov |
| Last updated | 2018-08-10 | ClinicalTrials.gov |
Registered outcomes 18
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Change from baseline Glycemic Response | baseline (-20 min), and 10, 30, 60, and 90 min post-drink consumption | Blood samples will be collected via finger-prick method to assess glycemic response (blood glucose, mmol/L) | ClinicalTrials.gov |
| Primary | Change from baseline verbal declarative memory | baseline (-20 min), and 10, 30, 60, and 90 min post-drink consumption | Cognitive function test of verbal declarative memory | ClinicalTrials.gov |
| Primary | Change from baseline working memory | baseline (-20 min), and 10, 30, 60, and 90 min post-drink consumption | The n-back test consists of 2 levels, 1-back and 2-back, where letters are presented on the screen one at a time. During the 1-back level, participants need to determine if the presented letter is the same as the one letter presented 1 before it or not (by selected 'match' or 'no match' on the side of the screen) and during 2-back need to do determine if it is the same letter as the one presented 2 letters prior. | ClinicalTrials.gov |
| Primary | Change from baseline executive functioning | baseline (-20 min), and 10, 30, 60, and 90 min post-drink consumption | The Stroop test consists of one word appearing on the screen written in either blue, red, yellow or green. There are 24 congruent trials where the presented word is the name of the colour it is written it (i.e. 'red' appearing in the colour red), 24 incongruent trials where the word written is a colour word different from the one it is written in (i.e. 'red' appearing in the colour green), and 10 neutral trials where non-colour words appear (i.e. 'tape' appearing in yellow). The participant is asked to tap the corresponding colour that the word is written in as quickly as possible. | ClinicalTrials.gov |
| Secondary | Change from baseline salivary cortisol response | baseline (-20 min), and 10 and 30 min post-drink consumption | Saliva samples will be collected via passive drool method to assess salivary cortisol response (ug/dL) | ClinicalTrials.gov |
| Secondary | Change form baseline Subjective Appetite | baseline (-20 min), and 10, 30, 60, and 90 min post-drink consumption | 100-mm Visual Analogue Scales (VAS) will be used to assess appetite | ClinicalTrials.gov |
| Secondary | Change from baseline aggression | baseline (-20 min), and 10, 30, 60, and 90 min post-drink consumption | 100-mm Visual Analogue Scales (VAS) will be used to assess aggression | ClinicalTrials.gov |
| Secondary | Change from baseline anger | baseline (-20 min), and 10, 30, 60, and 90 min post-drink consumption | 100-mm Visual Analogue Scales (VAS) will be used to assess anger | ClinicalTrials.gov |
| Secondary | Change from baseline excitement | baseline (-20 min), and 10, 30, 60, and 90 min post-drink consumption | 100-mm Visual Analogue Scales (VAS) will be used to assess excitement | ClinicalTrials.gov |
| Secondary | Change from baseline disappointment | baseline (-20 min), and 10, 30, 60, and 90 min post-drink consumption | 100-mm Visual Analogue Scales (VAS) will be used to assess disappointment | ClinicalTrials.gov |
| Secondary | Change from baseline happiness | baseline (-20 min), and 10, 30, 60, and 90 min post-drink consumption | 100-mm Visual Analogue Scales (VAS) will be used to assess happiness | ClinicalTrials.gov |
| Secondary | Change from baseline upset | baseline (-20 min), and 10, 30, 60, and 90 min post-drink consumption | 100-mm Visual Analogue Scales (VAS) will be used to assess upset | ClinicalTrials.gov |
| Secondary | Change form baseline frustration | baseline (-20 min), and 10, 30, 60, and 90 min post-drink consumption | 100-mm Visual Analogue Scales (VAS) will be used to assess frustration | ClinicalTrials.gov |
| Secondary | Change from baseline alertness | baseline (-20 min), and 10, 30, 60, and 90 min post-drink consumption | 100-mm Visual Analogue Scales (VAS) will be used to assess alertness | ClinicalTrials.gov |
| Secondary | Change from baseline sadness | baseline (-20 min), and 10, 30, 60, and 90 min post-drink consumption | 100-mm Visual Analogue Scales (VAS) will be used to assess sadness | ClinicalTrials.gov |
| Secondary | Change from baseline tension | baseline (-20 min), and 10, 30, 60, and 90 min post-drink consumption | 100-mm Visual Analogue Scales (VAS) will be used to assess tension | ClinicalTrials.gov |
| Secondary | Change from baseline exhaustion | baseline (-20 min), and 10, 30, 60, and 90 min post-drink consumption | 100-mm Visual Analogue Scales (VAS) will be used to assess exhaustion | ClinicalTrials.gov |
| Secondary | Change from baseline sleepiness | baseline (-20 min), and 10, 30, 60, and 90 min post-drink consumption | 100-mm Visual Analogue Scales (VAS) will be used to assess sleepiness | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|---|---|
| 32814852 | DERIVED | PubMed |
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| 1-Back Task | Primary outcome | ConductCognition |
| 2-Back Task | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)